FDA
label_change
· 2025-07-11
FDA Approved: TESTOSTERONE CYPIONATE — Supplemental Application (Hospira, Inc.)
Summary
FDA approves a supplemental application for TESTOSTERONE CYPIONATE (Hospira, Inc.), resulting in labeling changes for this testosterone replacement therapy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TESTOSTERONE CYPIONATE (TESTOSTERONE CYPIONATE)